Victoria Wan is an associate in the Data & Technology Transactions Practice in Latham & Watkins’ London office.
Ms. Wan advises EU and global clients across all market sectors on global data privacy and cybersecurity matters. She has particular experience advising on European data privacy legislation, including the General Data Protection Regulation (GDPR).
Ms. Wan also represents clients and assists deal teams in M&A transactions in relation to commercial contracts and intellectual property.
Ms. Wan trained in the firm’s London office, gaining experience in leveraged finance, benefits and compensation, and capital markets in addition to data and technology. Ms. Wan is an active member of Latham’s First Generation Professionals Group.
Ms. Wan’s experience includes advising:
- A large American semiconductor company on a multibillion-dollar purchase of a UK technology company on commercial contracts, IP, IT and data protection due diligence, and deal documentation
- A publicly listed China-headquartered technology and internet group on global data privacy compliance for cross-border streaming services and online games
- A significant social media company in matters before international regulatory bodies in connection with data breaches and other issues relating to privacy and security
- A leading global accountancy and consultancy firm on its global privacy impact assessment (PIA) process to minimize privacy and security risks, and achieve compliance with global information laws for new systems and tools
- Various clients on intellectual property matters throughout the life cycle of M&A transactions, from conducting due diligence to integration
- Various clients in connection with GDPR compliance, data protection gap analysis, and data protection policies
- BC Partners on IP, contracts, data protection, and regulatory matters related to the acquisition of a majority interest in Synthon International Holding B.V., a global market leader in the development of complex generics
- Various pharmaceutical and medical technology companies on various agreements for the conduct of clinical trials in the EU, including GDPR compliance aspects of such trials